Hydrolysis of the rutinose-conjugates flavonoids rutin and hesperidin by the gut microbiota and bifidobacteria

Nutrients

Volumn 7, Issue 4, 2015, Pages 2788-2800

  Amaretti, Alberto ^a   Raimondi, Stefano ^a   Leonardi, Alan ^a   Quartieri, Andrea ^a   Rossi, Maddalena ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Bifidobacterium; Hesperetin; Hesperidin; Polyphenols; Quercetin; Rutin; Rutinosides

Indexed keywords

FLAVANONE DERIVATIVE; FLAVONOL DERIVATIVE; HESPERETIN; HESPERIDIN; QUERCETIN; RUTOSIDE; ALPHA-L-RHAMNOSIDASE; DISACCHARIDE; GLYCOSIDASE; PROBIOTIC AGENT; RUTINOSE;

ADULT; ARTICLE; BIFIDOBACTERIUM; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM PSEUDOCATENULTUM; BIOAVAILABILITY; BIOTRANSFORMATION; FEMALE; FERMENTATION; HUMAN; HYDROLYSIS; INTESTINE FLORA; MALE; NONHUMAN; NORMAL HUMAN; CELL CULTURE; FECES; METABOLISM; MICROBIOLOGY; MIDDLE AGED;

BIFIDOBACTERIUM; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM PSEUDOCATENULATUM;

ADULT; BIFIDOBACTERIUM; CELLS, CULTURED; DISACCHARIDES; FECES; FEMALE; FERMENTATION; FLAVANONES; GASTROINTESTINAL MICROBIOME; GLYCOSIDE HYDROLASES; HEALTHY VOLUNTEERS; HESPERIDIN; HUMANS; HYDROLYSIS; MALE; MIDDLE AGED; PROBIOTICS; RUTIN;

EID: 84927942298     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7042788     Document Type: Article

References (29)

1. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
2. Graf, B.A.; Milbury, P.E.; Blumberg, J.B. Flavonols, flavones, flavanones, and human health: Epidemiological evidence. J. Med. Food 2005, 8, 281-290.
3. Chidambara Murthy, K.N.; Kim, J.; Vikram, A.; Patil, B.S. Differential inhibition of human colon cancer cells by structurally similar flavonoids of citrus. Food Chem. 2012, 132, 27-34.
4. Roohbakhsh, A.; Parhiz, H.; Soltani, F.; Rezaee, R.; Iranshahi, M. Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sci. 2015, 124, 64-74.
5. DuPont, M.S.; Day, A.J.; Bennett, R.N.; Mellon, F.A.; Kroon, P.A. Absorption of kaempferol from endive, a source of kaempferol-3-glucuronide, in humans. Eur. J. Clin. Nutr. 2004, 58, 947-954.
6. Hollman, P.C., de Vries, J.H.; van Leeuwen, S.D.; Mengelers, M.J.; Katan, M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 1995, 62, 1276-1282.
7. Hollman, P.C.; van Trijp, J.M.; Buysman, M.N.; van der Gaag, M.S.; Mengelers, M.J.; de Vries, J.H.; Katan, M.B. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett. 1997, 418, 152-156.
8. Manach, C.; Morand, C.; Demigné, C.; Texier, O.; Régérat, F.; Rémésy, C. Bioavailability of rutin and quercetin in rats. FEBS Lett. 1997, 409, 12-16.
9. Hollman, P.C.; Bijsman, M.N.; van Gameren, Y.; Cnossen, E.P.; de Vries, J.H.; Katan, M.B. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic. Res. 1999, 31, 569-573.
10. Carbonaro, M., Grant, G. Absorption of quercetin and rutin in rat small intestine. Ann. Nutr. MeTable 2005, 49, 178-182.
11. Olthof, M.R.; Hollman, P.C.; Buijsman, M.N.; van Amelsvoort, J.M.; Katan, M.B. Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J. Nutr. 2003, 133, 1806-1814.
12. Rechner, A.R.; Smith, M.A.; Kuhnle, G.; Gibson, G.R.; Debnam, E.S.; Srai, S.K.; Moore, K.P.; Rice-Evans, C.A. Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products. Free Radic. Biol. Med. 2004, 36, 212-225.
13. Shanahan, F.; Dinan, T.G.; Ross, P.; Hill, C. Probiotics in transition. Clin. Gastroenterol. Hepatol. 2012, 10, 1220-1224.
14. Chong, E.S. A potential role of probiotics in colorectal cancer prevention: Review of possible mechanisms of action. World J. Microbiol. Biotechnol. 2014, 30, 351-374.
15. Prakash, S.; Tomaro-Duchesneau, C.; Saha, S.; Rodes, L.; Kahouli, I.; Malhotra, M. Probiotics for the prevention and treatment of allergies, with an emphasis on mode of delivery and mechanism of action. Curr. Pharm. Des. 2014, 20, 1025-1037.
16. Rossi, M.; Amaretti, A. Probiotic Properties of Bifidobacteria. In Bifidobacteria: Genomics and Molecular Aspects; van Synderen, D.,Mayo, B., Eds.; Horizon Scientific Press: Rowan House, UK, 2010; pp. 97-123.
17. Rossi, M.; Amaretti, A.; Leonardi, A.; Raimondi, S.; Simone, M.; Quartieri, A. Potential impact of probiotic consumption on the bioactivity of dietary phytochemicals. J. Agric. Food Chem. 2013, 61, 9551-6558.
18. Lee, J.H.; O'Sullivan, D.J. Genomic insights into bifidobacteria. Microbiol. Mol. Biol. Rev. 2010, 74, 378-416.
19. Amaretti, A.; Bernardi, T.; Leonardi, A.; Raimondi, S.; Zanoni, S.; Rossi, M. Fermentation of xylo-oligosaccharides by Bifidobacterium adolescentis DSMZ 18350: Kinetics, metabolism, and β-xylosidase activities. Appl. Microbiol. Biotechnol. 2013, 97, 3109-3117.
20. Raimondi, S.; Roncaglia, L.; de Lucia, M.; Amaretti, A.; Leonardi, A. Pagnoni, U.M.; Rossi, M. Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Appl. Microbiol. Biotechnol. 2009, 81, 943-950.
21. Roncaglia, L.; Amaretti, A.; Raimondi, S.; Leonardi, A.; Rossi, M. Role of bifidobacteria in the activation of the lignan secoisolariciresinol diglucoside. Appl. Microbiol. Biotechnol. 2011, 92, 159-168.
22. Tomas-Barberan, F.; García-Villalba, R.; Quartieri, A.; Raimondi, S.; Amaretti, A.; Leonardi, A.; Rossi, M. In vitro transformation of chlorogenic acid by human gut microbiota. Mol. Nutr. Food Res. 2014, 58, 1122-1131.
23. Raimondi, S.; Anighoro, A.; Quartieri, A.; Amaretti, A.; Tomás-Barberán, F.A.; Rastelli, G.; Rossi, M. Role of bifidobacteria in the hydrolysis of chlorogenic acid. MicrobiologyOpen 2015, 4, 41-52.
24. Clavel, T.; Borrmann, D.; Braune, A.; Doré, J.; Blaut, M. Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. Anaerobe 2006, 12, 140-147.
25. Aura, A.M.; O'Leary, K.A.; Williamson, G.; Ojala, M.; Bailey, M.; Puupponen-Pimiä, R.; Nuutila, A.M.; Oksman-Caldentey, K.M.; Poutanen, K. Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. J. Agric. Food Chem. 2002, 50, 1725-1730.
26. Van den Broek, L.A.; Hinz, S.W.; Beldman, G.; Vincken, J.P.; Voragen, A.G. Bifidobacterium carbohydrases-their role in breakdown and synthesis of (potential) prebiotics. Mol. Nutr. Food Res. 2008, 52, 146-163.
27. Aura, A.M.; Martin-Lopez, P.; O'Leary, K.A.; Williamson, G.; Oksman-Caldentey, K.M.; Poutanen, K.; Santos-Buelga, C. In vitro metabolism of anthocyanins by human gut microflora. Eur. J. Nutr. 2005, 44, 133-142.
28. Bang, S.H.; Hyun, Y.J.; Shim, J.; Hong, S.W.; Kim, D.H. Metabolism of Rutin and Poncirin by Human Intestinal Microbiota and Cloning of Their Metabolizing α-L-Rhamnosidase from Bifidobacterium dentium. J. Microbiol. Biotechnol. 2015, 25, 18-25.
29. Alegría, A.; Delgado, S.; Guadamuro, L.; Flórez, A.B.; Felis, G.E.; Torriani, S.; Mayo, B. The genome of Bifidobacterium pseudocatenulatum IPLA 36007, a human intestinal strain with isoflavone-activation activity. Gut Pathog. 2014, 6, 31.